Severe CMV infection after chemo-immunotherapy with dose- reduced bendamustine and rituximab in an old mantle cell lymphoma patient
We discuss the case of a 74-year old male patient with mantle cell lymphoma, who faced severe CMV infection after the fifth cycle of first-line chemo-immunotherapy with a dose-reduced bendamustine and rituximab regimen.
Enregistré dans:
| Auteurs principaux: | , , , , , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
PAGEPress Publications
2021-08-01
|
| Collection: | Mediterranean Journal of Hematology and Infectious Diseases |
| Sujets: | |
| Accès en ligne: | https://www.mjhid.org/index.php/mjhid/article/view/4664 |
| Tags: |
Pas de tags, Soyez le premier à ajouter un tag!
|